價格：免費
更新日期：2019-07-19
檔案大小：因裝置而異
目前版本：因裝置而異
版本需求：Android 因裝置而異
官方網站：https://stemiindia.com/
Email：stemicardiacare@gmail.com
聯絡地址：隱私權政策
ST Elevation Myocardial Infarction (STEMI) is one of the most challenging clinical conditions in cardiology but also the most gratifying when treated promptly and appropriately. Recent advances in the management of STEMI have shown the prompt treatment can save lives and restore normal cardiac function. However, for treatment to be successful time is crucial, and for this teamwork is critical. Delay or sub optimal management at any stage can affect outcomes.
The National Commission on Macro-economics and Health has projected the evolving epidemic of coronary artery disease in India - 60 million patients with CHD by the year 2015 with a yearly mortality close to 3 million. A substantial number of this will be due to acute STEMI or the delayed consequences of STEMI. Though the US and Europe have substantantially fewer STEMI, the national bodies have formulated appropriate guidelines and there are audits and attempts to encourage and monitor adherence. Unfortunately there is no focussed training program for STEMI and no national guideline or policy in India. It is to fill this lacuna, that a 'not for profit' national organisation devoted exclusively to STEMI care in India has been formed.
